Ken Griffin Neurosense Therapeutics LTD Wt Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neurosense Therapeutics LTD Wt stock. As of the latest transaction made, Citadel Advisors LLC holds 25,274 shares of NRSNW stock, worth $11,626. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,274

Previous 29,464 14.22%

Holding current value

$11,626

Previous $6,000 50.0%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.13 - $0.27 $544 - $1,131	-4,190 Reduced 14.22%	25,274 $3,000
Q2 2024 Aug 14, 2024	SELL	$0.1 - $0.5 $1,867 - $9,337	-18,674 Reduced 38.79%	29,464 $6,000
Q1 2024 May 15, 2024	BUY	$0.08 - $0.5 $3,851 - $24,069	48,138 New	48,138 $20,000
Q3 2023 Nov 14, 2023	SELL	$0.11 - $0.28 $2,898 - $7,376	-26,346 Reduced 69.45%	11,588 $1,000
Q2 2023 Aug 14, 2023	BUY	$0.2 - $0.46 $1,064 - $2,448	5,323 Added 16.32%	37,934 $9,000
Q1 2023 May 15, 2023	BUY	$0.16 - $0.52 $5,217 - $16,957	32,611 New	32,611 $12,000

Others Institutions Holding NRSNW

# of Institutions

Shares Held

271K

Call Options Held

Put Options Held

View Full List

About NEUROSENSE THERAPEUTICS LTD WT

Ticker NRSNW

More about NRSNW

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account